Table 1.
Patients characteristics
| Characteristics | Number of patients | Percentage |
|---|---|---|
| Age |
|
|
| ≤ 60 |
12 |
38.7 |
| > 60 |
19 |
61.3 |
| Gender |
|
|
| Male |
23 |
74.2 |
| Female |
8 |
25.8 |
| ECOG PS |
|
|
| 0-1 |
27 |
87.1 |
| 2-4 |
4 |
12.9 |
| B symptom |
|
|
| Absent |
14 |
48.3 |
| Present |
15 |
51.7 |
| Bulky disease |
|
|
| Absent |
21 |
67.7 |
| Present |
10 |
32.3 |
| LDH |
|
|
| Normal |
4 |
12.9 |
| Elevated |
27 |
87.1 |
| Primary site of adrenal gland |
|
|
| Unilateral |
12 |
38.7 |
| Bilateral |
19 |
61.3 |
| Adrenal insufficiency |
|
|
| Absent |
10 |
62.5 |
| Present |
6 |
37.5 |
| Ann Arbor stage |
|
|
| IE, IIE |
5 |
16.1 |
| IIIE, IV |
26 |
83.9 |
| Number of extranodal sites |
|
|
| 0-1 |
7 |
22.6 |
| 2 or more |
24 |
77.4 |
| Ki-67 LI |
|
|
| > 80% |
11 |
57.9 |
| ≤ 80% |
8 |
42.1 |
| IPI |
|
|
| Low/Low-intermediate |
8 |
25.8 |
| High-intermediate/High | 23 | 74.2 |
ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase; Ki-67 LI, Ki-67 labeling Index; IPI, International Prognostic Index.